Hypoglycemic agent
AssigneesRiken, Japan Science and Technology Agency, Kunio SUZUKI
InventorsKunio Suzuki, Kohji Hirata, Rie Konno, Miwa Moriizumi
Life of this patent
Estimating the term…
Abstract
A hypoglycemic agent comprising a compound selected from the group consisting of 24-alkylcholestan-3-ones and 24-alkylcholesten-3-ones (for example, 24-alkylcholestan-3-ones, 24-alkylcholestmonoen-3-ones, 24-alkylcholestdien-3-ones, 24-alkylcholesttrien-3-ones, or 24-alkylcholesttetraen-3-ones, preferably 5-campesten-3-one) as an active ingredient. The agent can be used for improvement of hyperglycemia resulting from diseases such as diabetes, and can be used as a safe medicament without side effects such as hypoglycemia or diarrhea.
Claims17
A method of improving hyperglycemia of a mammal, which comprises administering a therapeutically effective amount of at least one compound of 24-alkylcholestan-3-ones and 24-alkylcholesten-3-ones compounds to the mammal.
Dependencies are inferred from the claim text.